Outsourced Pharma Capacity Update (April 2025): Fill/Finish

Discover how FUJIFILM Diosynth Biotechnologies’ end-to-end Drug Product and Finished Goods capabilities support the full product lifecycle of biologics through an integrated global kojoX network designed for scalability, speed, supply chain agility and resilience.

Henrik Herrmann, Executive Director, Technology and Business Development, Drug Product/Finished Goods at FUJIFILM Diosynth Biotechnologies, will present an update on the current and future state of our Drug Product and Finished Goods capabilities.

Register here.